Principal Investigators

    Endmann

    Institution

    UCB Pharma GmbH

    Contact information of lead PI

    Country

    Germany

    Title of project or programme

    Identification and characterization of Novel drug targets in neurodegenerative diseases by RNAi screening

    Source of funding information

    Federal Ministry of Education and Research (BMBF)

    Total sum awarded (Euro)

    € 568,589

    Start date of award

    01/02/2015

    Total duration of award in years

    1.9

    The project/programme is most relevant to:

    Neurodegenerative disease in general

    Keywords

    Research Abstract

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Germany
Diseases: Neurodegenerative disease in general
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF